To assess the efficacy of PIKfyve inhibitors against SARS-CoV-2 in vitro, VeroE6 or A549/hACE2 cells were pretreated with various concentration of PIKfyve inhibitors 2 h prior to infection with SARS-CoV-2 expressing green fluorescent protein (GFP). Here, PIKFYVE is linked to infection.